Beijing Shijitan Hospital

Futó vizsgálatok

• Toboroz

  A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants

  NCT07784699· 1. fázis· Gan & Lee Pharmaceuticals.· Forrás

• Toboroz

  Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring

  NCT07747701· Beijing Shijitan Hospital, Capital Medical University· Forrás

• Toboroz

  Early Identification and Diagnosis of BAD-related Stroke

  NCT07693816· Peking Union Medical College Hospital· Forrás

• Toboroz

  Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation

  NCT07556068· Beijing Shijitan Hospital, Capital Medical University· Forrás

• Toboroz

  A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

  NCT07189065· 2. fázis· Guangzhou Lupeng Pharmaceutical Company LTD.· Forrás

• Toboroz

  Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

  NCT07205432· 1. fázis· Shanghai Xitaili Biomedicine Technology co., Ltd.· Forrás

• Még nem toboroz

  Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

  NCT06374823· 4. fázis· Capital Medical University· Forrás

• Fut, nem toboroz

  A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

  NCT05388669· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás

• Meghívásos bevonás

  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  NCT03683186· 3. fázis· United Therapeutics· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Stroke (szélütés)4 toboroz
• Elhízás2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Koszorúér-betegség1 toboroz
• Magas vérnyomás1 toboroz
• Pulmonális artériás hipertónia1 toboroz

Lezárt vizsgálatok

• Lezárult

  Safety and Efficacy of Selective Intra-Arterial Cooling Infusion Combined With EVT in Acute Ischemic Stroke

  NCT06485427· Beijing Shijitan Hospital, Capital Medical University· Forrás

• Lezárult

  Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

  NCT06037889· 3. fázis· Peking Union Medical College Hospital· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

  NCT05171075· 3. fázis· Anthos Therapeutics, Inc.· Forrás

• Leállították

  A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

  NCT05171049· 3. fázis· Anthos Therapeutics, Inc.· Forrás

• Leállították

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· 3. fázis· Actelion· Forrás

• Lezárult

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· 3. fázis· United Therapeutics· Forrás

• Lezárult

  Prospective, Observational, Real-world Oral Malignant Tumors Study

  NCT02395367· Beijing Stomatological Hospital, Capital Medical University· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Diabetic foot ulcer7 munka · 0 vizsgálat